Results 81 to 90 of about 38,539 (238)

Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Reticular erythematous mucinosis is a rare dermatosis with a challenging diagnosis. To date, its dermoscopic features have not been well characterised in the literature. Only a limited number of case reports have described dermoscopic findings that may be indicative of the disorder, including the presence of dotted and linear vessels, as well ...
Grażyna Kamińska‐Winciorek   +4 more
wiley   +1 more source

Anetoderma: Is It a Sign of Autoimmunity?

open access: yesCase Reports in Dermatology, 2009
Anetoderma is a rare elastolytic disorder characterized by circumscribed areas of flaccid skin due to the loss of elastic tissue in the dermis. Primary anetoderma is frequently observed in patients with autoimmune diseases or abnormalities especially ...
Hessa Al Buainain, Mohamed Allam
doaj   +1 more source

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study [PDF]

open access: yes, 2013
We determined whether any individual cancers are increased or decreased in a cohort of 595 patients with systemic lupus erythematosus (SLE) followed for up to 32 years at the University College London Hospitals Lupus Clinic, looking for any associated ...
Dey, D, Isenberg, DA, Kenu, E
core   +1 more source

The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies

open access: yesHaematologica, 2008
Background To identify the mechanisms of the hypercoagulability associated with antiphospholipid antibodies, we investigated antibody-mediated platelet activation and interference of antibodies with phospholipid-dependent reactions.Design and Methods We ...
Aurelie Membre   +6 more
doaj   +1 more source

The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis [PDF]

open access: yes, 2016
Antiphospholipid antibodies (aPL) occur in patients with multiple sclerosis (MS) with a number of studies reporting elevated levels; their exact prevalence and pathogenic role remain unclear. Epidemiological studies associate MS with an increased risk of
Anatolitou, A   +10 more
core   +1 more source

Antiphospholipid antibody testing

open access: yesMedicina Clínica
Antiphospholipid antibodies (aPL) are a family of autoantibodies targeting phospholipid-binding proteins and are associated with several clinical settings, and most notably define the antiphospholipid syndrome (APS). These antibodies can be identified using a variety of laboratory tests, which include both solid-phase immunological assays and ...
Savino, Sciascia   +2 more
openaire   +2 more sources

Extensive Pulmonary Embolism in late pregnancy associated with Anticardiolipin Antibodies [PDF]

open access: yes, 2004
The leading cause of morbidity and mortality during pregnancy and the puerperium is venous thromboembolism. Though uncommon, the risk is five times higher in a pregnant woman than in a non-pregnant woman of similar age.1,2 In pregnancy, all three ...
Brincat, Mark P.   +5 more
core  

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease [PDF]

open access: yes, 2015
AIM: To assess the prevalence and stability of different antiphospholipid antibodies (APLAs) and their association with disease phenotype and progression in inflammatory bowel diseases (IBD) patients.
Altorjay, István   +11 more
core   +1 more source

Clinical relevance of silent red blood cell autoantibodies. [PDF]

open access: yes, 2017
.
Alessandri, C   +14 more
core   +1 more source

Association of anticardiolipin, antiphosphatidylserine, anti-β2 glycoprotein I, and antiphosphatidylcholine autoantibodies with canine immune thrombocytopenia [PDF]

open access: yes, 2016
β2GPI expression and identification.
Chau-Loong Tsang   +12 more
core   +4 more sources

Home - About - Disclaimer - Privacy